Wang et al. (2020) studied the potential of composite probiotics to alleviate T2DM by modulating intestinal microbiota and enhancing the expression of glucagon like peptide-1 (GLP-1) in db/db mice [140]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.